Jeffrey Tate - 20 Apr 2023 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Operating Officer, Director
Signature
/s/ Jeffrey Tate
Issuer symbol
CYTH
Transactions as of
20 Apr 2023
Net transactions value
+$25,001
Form type
4
Filing time
24 Apr 2023, 11:00:41 UTC
Previous filing
09 Mar 2023
Next filing
23 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTH Common Stock Purchase $21,258 +29,941 +93% $0.7100 62,101 20 Apr 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Warrant to Purchase Common Stock Purchase $3,743 +29,941 $0.1250* 29,941 20 Apr 2023 Common Stock 29,941 $0.7100 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.